Functional interaction between monoamine plasma membrane transporters and the synaptic PDZ domain-containing protein PICK1

被引:253
作者
Torres, GE
Yao, WD
Mohn, AR
Quan, H
Kim, KM
Levey, AI
Staudinger, J
Caron, MG [1 ]
机构
[1] Duke Univ, Med Ctr, Howard Hughes Med Inst, Dept Cell Biol, Durham, NC 27710 USA
[2] Emory Univ, Dept Neurol, Atlanta, GA 30322 USA
[3] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA
关键词
D O I
10.1016/S0896-6273(01)00267-7
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
PDZ domain-containing proteins play an important role in the targeting and localization of synaptic membrane proteins. Here, we report an interaction between the PDZ domain-containing protein PICK1 and monoamine neurotransmitter transporters in vitro and in vivo. In dopaminergic neurons, PICK1 colocalizes with the dopamine transporter (DAT) and forms a stable protein complex. Coexpression of PICK1 with DAT in mammalian cells and neurons in culture results in colocalization of the two proteins in a cluster pattern and an enhancement of DAT uptake activity through an increase in the number of plasma membrane DAT. Deletion of the PDZ binding site at the carboxyl terminus of DAT abolishes its association with PICK1 and impairs the localization of the transporter in neurons. These findings indicate a role for PDZ-mediated protein interactions in the localization, expression, and function of monoamine transporters.
引用
收藏
页码:121 / 134
页数:14
相关论文
共 50 条
  • [1] NEUROTRANSMITTER TRANSPORTERS - RECENT PROGRESS
    AMARA, SG
    KUHAR, MJ
    [J]. ANNUAL REVIEW OF NEUROSCIENCE, 1993, 16 : 73 - 93
  • [2] Neurotransmitter transporters as molecular targets for addictive drugs
    Amara, SG
    Sonders, MS
    [J]. DRUG AND ALCOHOL DEPENDENCE, 1998, 51 (1-2) : 87 - 96
  • [3] Apparsundaram S, 1998, J PHARMACOL EXP THER, V287, P744
  • [4] Barker Eric L., 1995, P321
  • [5] Altered brain serotonin homeostasis and locomotor insensitivity to 3,4-methylenedioxymethamphetamine ("ecstasy") in serotonin transporter-deficient mice
    Bengel, D
    Murphy, DL
    Andrews, AM
    Wichems, CH
    Feltner, D
    Heils, A
    Mössner, R
    Westphal, H
    Lesch, KP
    [J]. MOLECULAR PHARMACOLOGY, 1998, 53 (04) : 649 - 655
  • [6] Addiction, dopamine, and the molecular mechanisms of memory
    Berke, JD
    Hyman, SE
    [J]. NEURON, 2000, 25 (03) : 515 - 532
  • [7] THE DOPAMINE TRANSPORTER - IMMUNOCHEMICAL CHARACTERIZATION AND LOCALIZATION IN BRAIN
    CILIAX, BJ
    HEILMAN, C
    DEMCHYSHYN, LL
    PRISTUPA, ZB
    INCE, E
    HERSCH, SM
    NIZNIK, HB
    LEVEY, AI
    [J]. JOURNAL OF NEUROSCIENCE, 1995, 15 (03) : 1714 - 1723
  • [8] Immortalized dopamine neurons: A model to study neurotoxicity and neuroprotection
    Clarkson, ED
    Edwards-Prasad, J
    Freed, CR
    Prasad, KN
    [J]. PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1999, 222 (02): : 157 - 163
  • [9] Improvement of neurological deficits in 6-hydroxydopamine-lesioned rats after transplantation with allogeneic simian virus 40 large tumor antigen gene-induced immortalized dopamine cells
    Clarkson, ED
    La Rosa, FG
    Edwards-Prasad, J
    Weiland, DA
    Witta, SE
    Freed, CR
    Prasad, KN
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (03) : 1265 - 1270
  • [10] Copeland BJ, 1996, J PHARMACOL EXP THER, V277, P1527